APOE and atherosclerosis: Thus, through in vivo and in vitro studies, we have demonstrated that the Mas receptor agonist AVE0991 exhibits anti‐inflammatory properties affecting monocyte/macrophage differentiation and recruitment to the perivascular space at early stages of atherosclerosis in ApoE‐/‐ mice.